TAO CAPITAL MANAGEMENT LP
Q4 2024 Form 13-F
SAN FRANCISCO, CALIFORNIA
CIK 0001802967
· Institutional investment manager
$143.3M Reported Value Total
Reported value
$143.3M
Quarter over quarter
+29.8%
Holdings
10
Top-10 concentration
100.0%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
James Schwaba
Managing Director
Filing Navigation
13F Metrics
Loading 13F Metrics
Q4 2024 13F record
Q4 2024 13F filing summary
| Period of report | December 31, 2024 |
|---|---|
| Filed | February 13, 2025 |
| Form | 13F-HR |
| Reported value | $143.3M |
| Positions | 10 |
| Change in reported value | +29.8% |
| New positions | 0 |
| Exited positions | 0 |
| Position turnover | 0.0% |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 14, 2026
|
6 | $1.9B |
|
Q1 2026 13F
Filed May 14, 2026
|
8 | $118.8M |
|
Q4 2025 13F
Filed Feb 17, 2026
|
8 | $116.2M |
|
Q3 2025 13F
Filed Nov 12, 2025
|
10 | $132.2M |
|
Q2 2025 13F
Filed Aug 12, 2025
|
9 | $136.4M |
|
Q1 2025 13F
Filed May 12, 2025
|
9 | $116.1M |
|
Q4 2024 13F
Filed Feb 13, 2025
|
10 | $143.3M |
|
Q3 2024 13F
Filed Nov 8, 2024
|
10 | $110.4M |
|
Q2 2024 13F
Filed Aug 7, 2024
|
10 | $122.0M |
|
Q1 2024 13F
Filed May 9, 2024
|
10 | $105.5M |
|
Q4 2023 13F
Filed Feb 13, 2024
|
12 | $109.3M |
|
Q3 2023 13F
Filed Nov 13, 2023
|
11 | $129.1M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
14 | $136.6M |
|
Q1 2023 13F
Filed May 10, 2023
|
15 | $125.7M |
|
Q4 2022 13F
Filed Feb 9, 2023
|
16 | $133.0M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
16 | $152.5M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
16 | $144.5M |
|
Q1 2022 13F
Filed May 16, 2022
|
16 | $274.2M |
|
Q4 2021 13F
Filed Feb 11, 2022
|
15 | $327.3M |
|
Q3 2021 13F
Filed Nov 12, 2021
|
14 | $375.3M |
7 earlier quarters on file — choose one from the quarter menu above.
Top 10 holdings · Q4 2024
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | MDGL Madrigal Pharmaceuticals, Inc. | $40.3M | 28.11% |
| 2 | TWST Twist Bioscience Corporation | $38.5M | 26.88% |
| 3 | TSLA Tesla, Inc. | $34.8M | 24.31% |
| 4 | OUST Ouster, Inc. | $13.8M | 9.6% |
| 5 | H Hyatt Hotels Corporation | $11.0M | 7.67% |
| 6 | WRBY Warby Parker Inc. | $3.3M | 2.27% |
| 7 | MASS 908 Devices Inc. | $1.3M | 0.87% |
| 8 | SONDQ Sonder Holdings Inc. | $255.0K | 0.18% |
| 9 | BHILQ Benson Hill, Inc. | $99.9K | 0.07% |
| 10 | DNA Ginkgo Bioworks Holdings, Inc. | $55.8K | 0.04% |
Values as reported on the Q4 2024 Form 13F. Every position is in the holdings table below.